Keros Therapeutics, Inc. · NASDAQ:KROS

Madison Avenue Partners, LP reported a 6.40% stake in Keros Therapeutics, Inc. (Schedule 13G)

Event May 7, 2025 · Filed May 14, 2025

Madison Avenue Partners, LP reported a 6.40% stake in Keros Therapeutics, Inc., 2,614,402 shares, as a passive investor on May 7, 2025. Filed May 14, 2025 (Schedule 13G).

Stake
6.40%
Shares
2,614,402
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
Madison Avenue Partners, LP6.40%2,614,402
Madison Avenue International LP6.40%2,614,402
EMAI Management, LLC6.40%2,614,402
Madison Avenue GP, LLC6.40%2,614,402
Caraway Jackson Investments LLC6.40%2,614,402
Eli Samaha6.40%2,614,402

Source

View original at SEC

Related